Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1/A IPO registration
- 1.1 Exhibit 1.1
- 3.1 Exhibit 3.1
- 3.2 Exhibit 3.2
- 4.1 Exhibit 4.1
- 4.2 Exhibit 4.2
- 4.3 Exhibit 4.3
- 4.4 Exhibit 4.4
- 5.1 Exhibit 5.1
- 5.2 Exhibit 5.2
- 10.1 Exhibit 10.1
- 10.2 Exhibit 10.2
- 10.3 Exhibit 10.3
- 10.4 Exhibit 10.4
- 10.5 Exhibit 10.5
- 10.6 Exhibit 10.6
- 10.7 Exhibit 10.7
- 10.8 Exhibit 10.8
- 23.1 Exhibit 23.1
Associated filings
- 2 Mar 23 25-NSE/A Exchange delisting (amended)
- 17 Mar 21 424B4 Prospectus supplement with pricing info
- 16 Mar 21 EFFECT Notice of effectiveness
- 15 Mar 21 S-1/A IPO registration (amended)
- 11 Mar 21 S-1/A IPO registration (amended)
- 8 Mar 21 S-1/A IPO registration (amended)
-
4 Mar 21 S-1/A IPO registration (amended)
- 17 Feb 21 S-1 IPO registration
OCS similar filings
Filing view
External links
Exhibit 23.1
Independent Registered Public Accounting Firm’s Consent
We consent to the incorporation by reference in this Registration Statement of European Biotech Acquisition Corp. (the “Company”) on Amendment No. 1 to Form S-1 (File No. 333-253220) of our report dated February 5, 2021, which includes an explanatory paragraph as to the Company’s ability to continue as a going concern, with respect to our audit of the financial statements of European Biotech Acquisition Corp. as of January 18, 2021 and for the period from January 8, 2021 (inception) through January 18, 2021 appearing in the Registration Statement of the Company (File No. 333-253220).
/s/ Marcum llp
Marcum llp
New York, NY
March 4, 2021